JONATHAN E. WILSON,Petr Vachal,Ravi Kurukulasuriya
申请号:
US15028306
公开号:
US20160355474A1
申请日:
2014.10.06
申请国别(地区):
US
年份:
2016
代理人:
摘要:
3,3′-Disubstituted indoline compounds, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.